Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
使用生酮饮食增强放射化疗反应:一期试验
基本信息
- 批准号:8333333
- 负责人:
- 金额:$ 15.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAdverse effectsBloodBlood GlucoseCancer EtiologyCancer PatientCarbohydratesCase StudyCellsCessation of lifeChronicCombination Drug TherapyComplementConsumptionDNADataDefectDevelopmentDietDietary InterventionDiseaseEpilepsyFatty acid glycerol estersFutureGlucoseGlycemic IndexGlycolysisHumanHydrogen PeroxideInvestigationKetonesKetosesKetosisLipid PeroxidationMalignant neoplasm of brainMalignant neoplasm of lungMalignant neoplasm of pancreasMalignant neoplasm of prostateMetabolicMetabolismMitochondriaMusNatureNon-Small-Cell Lung CarcinomaNormal CellOperative Surgical ProceduresOutcomeOxidative StressPatientsPhase I Clinical TrialsPhase II/III TrialProductionProteinsRadiationRadiation therapyRadioRelative (related person)RespirationSerumSolutionsSurvival RateTestingTherapeuticToxic effectTranslatingUnited StatesUrineXenograft procedurebasecancer carecancer cellcancer therapycost effectivefeedingglucose metabolismglucose uptakeimprovedindexinginnovationketogenic dietmalignant stomach neoplasmmouse modelnovel therapeutic interventionoutcome forecastoxidationpre-clinicalresponsestandard carestem
项目摘要
DESCRIPTION (provided by applicant): Locally advanced non-small cell lung cancer (NSCLC) and pancreatic cancer both have a poor prognosis with five year survival rates ranging between 5-20%. The most common therapies include a combination of chemotherapy, radiation therapy, and when possible, surgery. However, given the poor outcomes, new complementary approaches which improve outcome are highly desirable. One promising and innovative complementary approach that potentially exploits fundamental metabolic differences between cancer cells and normal cells is the ketogenic diet (KD). Ketogenic diets are relatively non-toxic and have been used safely for years as a treatment for epilepsy. Ketogenic diets contain a high proportion of fat relative to protein and carbohydrates and result in elevated blood ketone levels and a lower glycemic index which force cells to rely more heavily on mitochondrial respiration, as opposed to glycolysis, for energy production. Cancer cells, relative to normal cells, have increased glucose uptake and are believed to exist in a state of chronic metabolic oxidative stress. It has been proposed, with significant supporting data, that cancer cells utilize increased glucose metabolism to generate reducing equivalents that are necessary to facilitate the decomposition of hydroperoxides as an adaptive response to metabolic oxidative stress caused by cancer cell specific dysfunctional mitochondrial O2 metabolism. If ketogenic diets limit glucose metabolism and force cells to derive energy from mitochondrial metabolism, it is reasonable to propose that these diets will also selectively enhance oxidative stress in cancer cells (relative to normal cells). The overarching hypothesis is that ketogenic diets (KD) will be clinically well tolerated and selectively enhance responses of non-small cell lung cancer (NSCLC) and pancreatic cancer to chemo-radio- sensitization via an oxidative stress mechanism. This is based on preliminary data in mice with human NSCLC or pancreas cancer xenografts fed KD during radiotherapy demonstrate enhanced therapeutic responses and increases in parameters indicative of oxidative stress with no evidence of adverse effects. To translate these exciting preclinical observations into human trials the current proposal will determine the tolerance of subjects with locally advanced NSCLC and pancreatic cancer to a prolonged (6.5-7.5 week) KD while receiving concurrent standard chemo-radiation therapy. Furthermore, subject blood will be analyzed for evidence of increases in parameters indicative of ketosis (serum ketones and blood glucose) as well as parameters of oxidative stress (lipid peroxidation, DNA oxidation, and protein oxidation). Successful completion of these studies will confirm the ability of subjects to tolerate a KD with concurrent chemo-radiation as well as assess the impact of the diet on metabolism and indices of oxidative stress. Successful completion of this study will allow for future trials to assess the potential for a KD to be used as an adjuvant to cancer therapy with the potential of increasing the efficacy of standard therapies for NSCLC and pancreatic cancer.
描述(申请人提供):局部晚期非小细胞肺癌(NSCLC)和胰腺癌预后较差,5年生存率在5-20%之间。最常见的治疗方法包括化疗、放射治疗,如果可能的话,还有手术。然而,鉴于不良的结果,改善结果的新的补充方法是非常可取的。生酮饮食(KD)是一种有前途的创新补充方法,可能利用癌细胞和正常细胞之间的基本代谢差异。生酮饮食相对无毒,多年来一直被安全用于治疗癫痫。生酮饮食中脂肪的比例高于蛋白质和碳水化合物,导致血酮水平升高,血糖指数降低,这迫使细胞更多地依赖线粒体呼吸,而不是糖酵解来产生能量。与正常细胞相比,癌细胞的葡萄糖摄取增加,被认为处于慢性代谢氧化应激状态。有重要的支持数据表明,癌细胞利用增加的葡萄糖代谢来产生减少等量物,这是促进氢过氧化物分解所必需的,是对癌细胞特异性线粒体O2代谢功能障碍引起的代谢氧化应激的适应性反应。如果生酮饮食限制了葡萄糖代谢并迫使细胞从线粒体代谢中获取能量,那么我们有理由提出,这些饮食也会选择性地增强癌细胞(相对于正常细胞)的氧化应激。总体假设是,生酮饮食(KD)在临床上具有良好的耐受性,并通过氧化应激机制选择性地增强非小细胞肺癌(NSCLC)和胰腺癌对化学放射增敏的反应。这是基于在放射治疗期间喂养KD的人类非小细胞肺癌或胰腺癌异种移植小鼠的初步数据显示,治疗反应增强,氧化应激参数增加,无不良反应的证据。为了将这些令人兴奋的临床前观察结果转化为人体试验,目前的建议将确定局部晚期非小细胞肺癌和胰腺癌患者在接受标准放化疗的同时延长(6.5-7.5周)KD的耐受性。此外,将分析受试者的血液,以确定是否有酮病指标(血清酮和血糖)以及氧化应激指标(脂质过氧化、DNA氧化和蛋白质氧化)升高的证据。这些研究的成功完成将证实受试者耐受KD与同步化学辐射的能力,并评估饮食对代谢和氧化应激指标的影响。这项研究的成功完成将允许未来的试验来评估KD作为癌症辅助治疗的潜力,并有可能提高非小细胞肺癌和胰腺癌标准治疗的疗效。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN M. BUATTI其他文献
JOHN M. BUATTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN M. BUATTI', 18)}}的其他基金
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
使用生酮饮食增强放射化疗反应:一期试验
- 批准号:
8175225 - 财政年份:2011
- 资助金额:
$ 15.36万 - 项目类别:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
定量成像评估癌症治疗试验中的反应
- 批准号:
8636907 - 财政年份:2010
- 资助金额:
$ 15.36万 - 项目类别:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
定量成像评估癌症治疗试验中的反应
- 批准号:
7891013 - 财政年份:2010
- 资助金额:
$ 15.36万 - 项目类别:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
定量成像评估癌症治疗试验中的反应
- 批准号:
8456899 - 财政年份:2010
- 资助金额:
$ 15.36万 - 项目类别:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
定量成像评估癌症治疗试验中的反应
- 批准号:
8244350 - 财政年份:2010
- 资助金额:
$ 15.36万 - 项目类别:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
定量成像评估癌症治疗试验中的反应
- 批准号:
8964178 - 财政年份:2010
- 资助金额:
$ 15.36万 - 项目类别:
Quantitative Imaging to Assess Response in Cancer Therapy Trials
定量成像评估癌症治疗试验中的反应
- 批准号:
8034225 - 财政年份:2010
- 资助金额:
$ 15.36万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 15.36万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 15.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 15.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 15.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Studentship